Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Enhancing early detection of cognitive impairment in primary care with the TabCAT-BHA 2025-07-01
  2. A novel DPP-4 inhibitor Gramcyclin A attenuates cognitive deficits in APP/PS1/tau triple transgenic mice via enhancing brain GLP-1-dependent glucose uptake 2022-01-28
  3. Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance 2018-09-13

Studies

3 studies carry this tag.

Date range

2018 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Experimental neurology 1
  • Phytotherapy research : PTR 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Enhancing early detection of cognitive impairment in primary care with the TabCAT-BHA

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-07-01 Cognitive tests and assessment

    TabCAT-BHA was well accepted and sustained, offering a scalable solution for cognitive impairment diagnosis in primary care.

  2. A novel DPP-4 inhibitor Gramcyclin A attenuates cognitive deficits in APP/PS1/tau triple transgenic mice via enhancing brain GLP-1-dependent glucose uptake

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Phytotherapy research : PTR 2022-01-28 Drug development

    Enhancing glucagon-like peptide 1 (GLP-1) signaling with a dipeptidyl peptidase IV (DPP-4) inhibitor might exert protective effects on Alzheimer's disease (AD).

  3. Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Experimental neurology 2018-09-13 Drug development

    Diabetes mellitus (DM) can increase the risk of Alzheimer's disease (AD) in patients.

All topic tags with their study counts